MiR-16 mimics exert their anti-cancer effects via multi-targeting of cyclin dependent kinases and the VEGF pathway inhibiting tumor growth together with inhibition of BCL2 which promotes apoptosis 291-293. The gene discussed is VEGFA; the disease is neoplasm.